Pharmacist-led intervention to reduce inappropriate continuation of targeted medications initiated in the acute care setting at hospital and ICU discharge

IF 1.3 Q4 PHARMACOLOGY & PHARMACY Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-02-08 DOI:10.1002/jac5.1924
Nandini Patel Pharm.D., Robert E. Dannemiller Pharm.D., Mary P. Kovacevic Pharm.D., Kevin M. Dube Pharm.D., Kenneth E. Lupi Pharm.D., Rachel C. Blum Pharm.D., Kaitlin E. Crowley Pharm.D.
{"title":"Pharmacist-led intervention to reduce inappropriate continuation of targeted medications initiated in the acute care setting at hospital and ICU discharge","authors":"Nandini Patel Pharm.D.,&nbsp;Robert E. Dannemiller Pharm.D.,&nbsp;Mary P. Kovacevic Pharm.D.,&nbsp;Kevin M. Dube Pharm.D.,&nbsp;Kenneth E. Lupi Pharm.D.,&nbsp;Rachel C. Blum Pharm.D.,&nbsp;Kaitlin E. Crowley Pharm.D.","doi":"10.1002/jac5.1924","DOIUrl":null,"url":null,"abstract":"<p>Pharmacist-led interventions may reduce the inappropriate continuation of acid-suppressive agents and antipsychotics temporarily initiated in the intensive care unit (ICU), but limited data exist for other medications. This study evaluated the impact of a pharmacist-led intervention on the number of medications inappropriately continued upon ICU and hospital discharge. This was a single-center, pre-post intervention analysis conducted in the medical and surgical ICUs at a tertiary academic medical center. The pre- and post-intervention groups included adults who were newly initiated on medications used for stress ulcer prophylaxis, delirium, agitation, wakefulness, sedation, and insomnia from December 1, 2021 to January 31, 2022 and December 12, 2022 to February 13, 2023, respectively. In the post-intervention group, pharmacists identified patients who were newly initiated on a medication of interest and documented in patients' charts via an electronic handoff tool utilizing a standardized template. The appropriateness of those medications was assessed daily, and pharmacists intervened when necessary. The number of medications inappropriately continued at ICU and hospital discharge and ICU and hospital lengths of stay were compared. Overall, 399 encounters were included in the final analysis, and a total of 459 medications were newly initiated in the ICU. There was no significant difference in the number of medications inappropriately continued at hospital discharge [22 (8.4%) vs. 10 (5.1%); <i>p</i> = 0.17]. Significantly fewer medications were inappropriately continued at ICU discharge in the post-intervention group [85 (32.3%) vs. 37 (18.9%); <i>p</i> &lt; 0.01]. The median ICU length of stay was significantly greater in the post-intervention group [4 (2–8) vs. 2 (1–6) days; <i>p</i> &lt; 0.01]. No significant difference was found in the median hospital length of stay [14 (7–26.5) vs. 16 (9–33.75) days; <i>p</i> = 0.08]. Use of an electronic handoff tool was associated with a significant reduction in the number of medications inappropriately continued at ICU discharge.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1924","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Pharmacist-led interventions may reduce the inappropriate continuation of acid-suppressive agents and antipsychotics temporarily initiated in the intensive care unit (ICU), but limited data exist for other medications. This study evaluated the impact of a pharmacist-led intervention on the number of medications inappropriately continued upon ICU and hospital discharge. This was a single-center, pre-post intervention analysis conducted in the medical and surgical ICUs at a tertiary academic medical center. The pre- and post-intervention groups included adults who were newly initiated on medications used for stress ulcer prophylaxis, delirium, agitation, wakefulness, sedation, and insomnia from December 1, 2021 to January 31, 2022 and December 12, 2022 to February 13, 2023, respectively. In the post-intervention group, pharmacists identified patients who were newly initiated on a medication of interest and documented in patients' charts via an electronic handoff tool utilizing a standardized template. The appropriateness of those medications was assessed daily, and pharmacists intervened when necessary. The number of medications inappropriately continued at ICU and hospital discharge and ICU and hospital lengths of stay were compared. Overall, 399 encounters were included in the final analysis, and a total of 459 medications were newly initiated in the ICU. There was no significant difference in the number of medications inappropriately continued at hospital discharge [22 (8.4%) vs. 10 (5.1%); p = 0.17]. Significantly fewer medications were inappropriately continued at ICU discharge in the post-intervention group [85 (32.3%) vs. 37 (18.9%); p < 0.01]. The median ICU length of stay was significantly greater in the post-intervention group [4 (2–8) vs. 2 (1–6) days; p < 0.01]. No significant difference was found in the median hospital length of stay [14 (7–26.5) vs. 16 (9–33.75) days; p = 0.08]. Use of an electronic handoff tool was associated with a significant reduction in the number of medications inappropriately continued at ICU discharge.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药剂师主导的干预措施,以减少在医院和重症监护室出院时不适当地继续使用在急症护理环境中启动的目标药物
药剂师主导的干预措施可减少重症监护室(ICU)中临时启用的抑酸剂和抗精神病药物的不当继续使用,但其他药物的相关数据却很有限。本研究评估了药剂师主导的干预措施对重症监护室和出院时不适当继续用药数量的影响。这是一项在一家三级学术医疗中心的内科和外科重症监护室进行的单中心、干预前和干预后分析。干预前组和干预后组分别包括 2021 年 12 月 1 日至 2022 年 1 月 31 日和 2022 年 12 月 12 日至 2023 年 2 月 13 日期间新开始使用应激性溃疡预防、谵妄、躁动、清醒、镇静和失眠药物的成人。在干预后组中,药剂师将确定新开始使用相关药物的患者,并通过使用标准化模板的电子交接工具在患者病历中进行记录。药剂师每天都会评估这些药物的适当性,并在必要时进行干预。对重症监护室和出院时继续用药不当的次数以及重症监护室和医院的住院时间进行了比较。最终分析共纳入了 399 次用药,其中在重症监护室新启用的药物共有 459 种。出院时继续使用的不当药物数量没有明显差异[22(8.4%)对10(5.1%);P = 0.17]。干预后组中,ICU出院时继续不当用药的人数明显减少[85 (32.3%) vs. 37 (18.9%);p < 0.01]。干预后组的重症监护室住院时间中位数明显长于干预前组 [4 (2-8) 天 vs. 2 (1-6) 天;p < 0.01]。中位住院时间无明显差异[14 (7-26.5) 天 vs. 16 (9-33.75) 天;p = 0.08]。使用电子交接工具可显著减少 ICU 出院时继续用药不当的情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
期刊最新文献
Issue Information A tale of two bills: Lessons learned in expanding pharmacist-led HIV pre-exposure and post-exposure prophylaxis Serving as a professional association board member: Benefits to leaders and their employers Unique model for pharmacist cross-coverage in the ambulatory care setting Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1